Pharma Capital

Collagen Solutions' Jamal Rushdy hails 'significant' growth in Asia-Pacific & Europe

Jamal Rushdy, chief executive of Collagen Solutions PLC (LON:COS) talks through the firm's results for the year to the end of March 2017.

 

View full COS profile

Collagen Solutions PLC Timeline

View All

© biotech Capital 2017

Biotech Capital, a subsidiary of Proactive Investors, acts as the vanguard for listed biotech companies to interact with institutional and highly capitalised investors.
Headquartered in London, Biotech Capital is led by a team of Europe's leading analysts and journalists, publishing daily content, covering all key movements in the Biotechnology market.